Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of Rheumatoid Arthritis
Subjects Global Disease Assessment of greater than equal to 20 mm on a visual analog scale
Discontinue all Biologics and Disease-modifying antirheumatic drugs (DMARDS) except for methotrexate
You may not be if
Received treatment with rituximab
Subjects who have received treatment with immunoadsorbtion columns (such as Prosorba columns), mycophenolate mofetil (Cellcept®), cyclosporine A or other calcineurin inhibitors, or D-Penicillamine
Clareo Health | Phase IIIB Subcutaneous Abatacept Monotherapy Study
